192 related articles for article (PubMed ID: 37946345)
1. Recent Advances in Pyrazole-based Protein Kinase Inhibitors as Emerging Therapeutic Targets.
Cetin A
Comb Chem High Throughput Screen; 2023 Nov; ():. PubMed ID: 37946345
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnology and Protection of Intellectual Property: Emerging Trends.
Siri JGS; Fernando CAN; De Silva SNT
Recent Pat Nanotechnol; 2020; 14(4):307-327. PubMed ID: 32532198
[TBL] [Abstract][Full Text] [Related]
3. Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades.
Imran M; Asdaq SMB; Khan SA; Unnikrishnan Meenakshi D; Alamri AS; Alsanie WF; Alhomrani M; Mohzari Y; Alrashed A; AlMotairi M; Alkhaldi EH; Alorabi AK; Alshrari AS; Tauseef M; Abida ; Alaqel SI; Alam O; Bakht MA
Pharmaceuticals (Basel); 2021 Jul; 14(8):. PubMed ID: 34451807
[TBL] [Abstract][Full Text] [Related]
4. The Race to Replace PDE5i: Recent Advances and Interventions to Treat or Manage Erectile Dysfunction: Evidence from Patent Landscape (2016-2021).
Islam MM; Naveen NR; Anitha P; Goudanavar PS; Rao GSNK; Fattepur S; Rahman MM; Shiroorkar PN; Habeebuddin M; Meravanige G; Telsang M; Nagaraja S; Asdaq SMB; Anwer MDK
J Clin Med; 2022 May; 11(11):. PubMed ID: 35683526
[TBL] [Abstract][Full Text] [Related]
5. Herbal Technological Prospects of
Alves LP; Dos Santos WM; de Souza ML; Rolim LA; Rolim-Neto PJ
Recent Pat Biotechnol; 2024; 18(3):241-256. PubMed ID: 37605394
[TBL] [Abstract][Full Text] [Related]
6. Digital pathology: A systematic evaluation of the patent landscape.
Cucoranu IC; Parwani AV; Vepa S; Weinstein RS; Pantanowitz L
J Pathol Inform; 2014; 5(1):16. PubMed ID: 25057430
[TBL] [Abstract][Full Text] [Related]
7. Novel Selective Histone Deacetylase 6 (HDAC6) Inhibitors: A Patent Review (2016-2019).
He X; Li Z; Zhuo XT; Hui Z; Xie T; Ye XY
Recent Pat Anticancer Drug Discov; 2020; 15(1):32-48. PubMed ID: 32065106
[TBL] [Abstract][Full Text] [Related]
8. Scenario of the Treatment of Arthritis with Natural Products.
Gallotti FCM; Serafini MR; Thomazzi SM
Recent Pat Inflamm Allergy Drug Discov; 2020; 14(2):95-105. PubMed ID: 32108012
[TBL] [Abstract][Full Text] [Related]
9. Novel Small Molecule Inhibitors of Programmed Cell Death (PD)-1, and its Ligand, PD-L1 in Cancer Immunotherapy: A Review Update of Patent Literature.
Kopalli SR; Kang TB; Lee KH; Koppula S
Recent Pat Anticancer Drug Discov; 2019; 14(2):100-112. PubMed ID: 30370857
[TBL] [Abstract][Full Text] [Related]
10. Systematic Analysis of Covalent and Allosteric Protein Kinase Inhibitors.
Xerxa E; Laufkötter O; Bajorath J
Molecules; 2023 Aug; 28(15):. PubMed ID: 37570774
[TBL] [Abstract][Full Text] [Related]
11.
Valadas LAR; de Oliveira Filho RD; Rodrigues Neto EM; Bandeira MAM; Fonteles MMF; Passos VF; Fiallos ACM; Lotif MAL; de Sena NJC; Dantas TCFB; Lima Soares I; Lobo PLD; Squassi AF
Evid Based Complement Alternat Med; 2021; 2021():9966738. PubMed ID: 34504542
[TBL] [Abstract][Full Text] [Related]
12. Technological development of microemulsions with perspectives for pain treatment: a patent review.
Lima MPD; Lopes EM; Gomes LDS; França ARS; Acha BT; Carvalho ALM; Almeida FRC
Expert Opin Ther Pat; 2018 Sep; 28(9):691-702. PubMed ID: 30175633
[TBL] [Abstract][Full Text] [Related]
13. Searching bioremediation patents through Cooperative Patent Classification (CPC).
Prasad R
Rev Environ Health; 2016 Mar; 31(1):53-6. PubMed ID: 26812756
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Substituted Pyrazole-Based Kinase Inhibitors in One Decade (2011-2020): Current Status and Future Prospects.
El-Gamal MI; Zaraei SO; Madkour MM; Anbar HS
Molecules; 2022 Jan; 27(1):. PubMed ID: 35011562
[TBL] [Abstract][Full Text] [Related]
15. Bixa orellana L. (Achiote, Annatto) as an antimicrobial agent: A scoping review of its efficiency and technological prospecting.
Coelho Dos Santos D; Silva Barboza AD; Ribeiro JS; Rodrigues Junior SA; Campos ÂD; Lund RG
J Ethnopharmacol; 2022 Apr; 287():114961. PubMed ID: 34968663
[TBL] [Abstract][Full Text] [Related]
16. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
17. Disambiguation of patent inventors and assignees using high-resolution geolocation data.
Morrison G; Riccaboni M; Pammolli F
Sci Data; 2017 May; 4():170064. PubMed ID: 28509897
[TBL] [Abstract][Full Text] [Related]
18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
19. What do patents tell us about microalgae in agriculture?
Murata MM; Ito Morioka LR; Da Silva Marques JB; Bosso A; Suguimoto HH
AMB Express; 2021 Nov; 11(1):154. PubMed ID: 34816320
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolytic Enzymes From Extremophilic Microorganisms in the Development of New Thrombolytic Therapies: Technological Prospecting.
Soares Bispo JR; de Oliveira Lima IG; da Silva MB; de Oliveira Feitosa A; Dos Santos ACM; Alexandre Moreira MS; Zambrano Passarini MR; Saraiva Câmara PEA; Rosa LH; Oliveira VM; de Queiroz AC; Fernandes Duarte AW
Recent Pat Biotechnol; 2021; 15(3):169-183. PubMed ID: 34353276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
